427 related articles for article (PubMed ID: 35729567)
1. Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltrates.
Fang Y; Liu J; Zhang Q; She C; Zheng R; Zhang R; Chen Z; Chen C; Wu J
World J Surg Oncol; 2022 Jun; 20(1):211. PubMed ID: 35729567
[TBL] [Abstract][Full Text] [Related]
2. VDAC1 Conversely Correlates with Cytc Expression and Predicts Poor Prognosis in Human Breast Cancer Patients.
Chen F; Yin S; Luo B; Wu X; Yan H; Yan D; Chen C; Guan F; Yuan J
Oxid Med Cell Longev; 2021; 2021():7647139. PubMed ID: 33680287
[TBL] [Abstract][Full Text] [Related]
3. Expression profiling of mitochondrial voltage-dependent anion channel-1 associated genes predicts recurrence-free survival in human carcinomas.
Ko JH; Gu W; Lim I; Zhou T; Bang H
PLoS One; 2014; 9(10):e110094. PubMed ID: 25333947
[TBL] [Abstract][Full Text] [Related]
4. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
5. Identification of PIMREG as a novel prognostic signature in breast cancer via integrated bioinformatics analysis and experimental validation.
Zhao W; Chang Y; Wu Z; Jiang X; Li Y; Xie R; Fu D; Sun C; Gao J
PeerJ; 2023; 11():e15703. PubMed ID: 37483962
[TBL] [Abstract][Full Text] [Related]
6. Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancer.
Chen F; Fan Y; Hou J; Liu B; Zhang B; Shang Y; Chang Y; Cao P; Tan K
Aging (Albany NY); 2021 Sep; 13(17):21671-21699. PubMed ID: 34518441
[TBL] [Abstract][Full Text] [Related]
7. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
8. Identification of prognostic biomarkers of breast cancer based on the immune-related gene module.
Wang R; Zeng H; Xiao X; Zheng J; Ke N; Xie W; Lin Q; Zhang H
Autoimmunity; 2023 Dec; 56(1):2244695. PubMed ID: 37584152
[TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of KLRB1 and its further association with immune cells in breast cancer.
Xu N; Meng X; Chu H; Yang Z; Jiao Y; Li Y
PeerJ; 2023; 11():e15654. PubMed ID: 37520246
[TBL] [Abstract][Full Text] [Related]
10. KIF2C is a prognostic biomarker associated with immune cell infiltration in breast cancer.
Liu S; Ye Z; Xue VW; Sun Q; Li H; Lu D
BMC Cancer; 2023 Apr; 23(1):307. PubMed ID: 37016301
[TBL] [Abstract][Full Text] [Related]
11. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
12. Silencing the Mitochondrial Gatekeeper VDAC1 as a Potential Treatment for Bladder Cancer.
Alhozeel B; Pandey SK; Shteinfer-Kuzmine A; Santhanam M; Shoshan-Barmatz V
Cells; 2024 Apr; 13(7):. PubMed ID: 38607066
[TBL] [Abstract][Full Text] [Related]
13. Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients.
Meng X; Wang L; He M; Yang Z; Jiao Y; Hu Y; Wang K
PLoS One; 2022; 17(6):e0269998. PubMed ID: 35771747
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive analysis of the expression, prognostic significance, and regulation pathway of G2E3 in breast cancer.
Shen Y; Xue J; Yu J; Jiang Y; Bu J; Zhu T; Gu X; Zhu X
World J Surg Oncol; 2022 Dec; 20(1):398. PubMed ID: 36517818
[TBL] [Abstract][Full Text] [Related]
15. Identification of prognostic biomarkers for breast cancer brain metastases based on the bioinformatics analysis.
Wu Z; Wan J; Wang J; Meng X; Qian H
Biochem Biophys Rep; 2022 Mar; 29():101203. PubMed ID: 35059509
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
He M; Hu C; Deng J; Ji H; Tian W
World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
[TBL] [Abstract][Full Text] [Related]
17. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
[TBL] [Abstract][Full Text] [Related]
18. A novel immune checkpoint-related gene signature for predicting overall survival and immune status in triple-negative breast cancer.
Liu J; Ling Y; Su N; Li Y; Tian S; Hou B; Luo S; Zhao L; Shi M
Transl Cancer Res; 2022 Jan; 11(1):181-192. PubMed ID: 35261895
[TBL] [Abstract][Full Text] [Related]
19. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer.
Gao T; Jiang B; Zhou Y; He R; Xie L; Li Y
Front Immunol; 2024; 15():1369892. PubMed ID: 38707897
[TBL] [Abstract][Full Text] [Related]
20. Upregulated GSDMB in Clear Cell Renal Cell Carcinoma Is Associated with Immune Infiltrates and Poor Prognosis.
Cui Y; Zhou Z; Chai Y; Zhang Y
J Immunol Res; 2021; 2021():7753553. PubMed ID: 34957313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
